Cystic fibrosis study to investigate real-world effects of new triple combination drug

(RCSI) Researchers at RCSI University of Medicine and Health Sciences are leading a new €3m study to investigate the real-world effects of the newest cystic fibrosis medications as they become available for people with CF.